
Clinical academic research in the time of Corona: A simulation study in England and a call for action
Author(s) -
Amitava Banerjee,
Michail Katsoulis,
Alvina Lai,
Laura Pasea,
Thomas A. Treibel,
Charlotte Manisty,
Spiros Denaxas,
Giovanni Quarta,
Harry Hemingway,
João L. Cavalcante,
Mahdad Noursadeghi,
James Moon
Publication year - 2020
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0237298
Subject(s) - psychological intervention , pandemic , population , medicine , clinical research , clinical trial , attrition , health care , covid-19 , family medicine , demography , nursing , environmental health , political science , disease , sociology , infectious disease (medical specialty) , pathology , law , dentistry
Objectives We aimed to model the impact of coronavirus (COVID-19) on the clinical academic response in England, and to provide recommendations for COVID-related research. Design A stochastic model to determine clinical academic capacity in England, incorporating the following key factors which affect the ability to conduct research in the COVID-19 climate: (i) infection growth rate and population infection rate (from UK COVID-19 statistics and WHO); (ii) strain on the healthcare system (from published model); and (iii) availability of clinical academic staff with appropriate skillsets affected by frontline clinical activity and sickness (from UK statistics). Setting Clinical academics in primary and secondary care in England. Participants Equivalent of 3200 full-time clinical academics in England. Interventions Four policy approaches to COVID-19 with differing population infection rates: “Italy model” (6%), “mitigation” (10%), “relaxed mitigation” (40%) and “do-nothing” (80%) scenarios. Low and high strain on the health system (no clinical academics able to do research at 10% and 5% infection rate, respectively. Main outcome measures Number of full-time clinical academics available to conduct clinical research during the pandemic in England. Results In the “Italy model”, “mitigation”, “relaxed mitigation” and “do-nothing” scenarios, from 5 March 2020 the duration (days) and peak infection rates (%) are 95(2.4%), 115(2.5%), 240(5.3%) and 240(16.7%) respectively. Near complete attrition of academia (87% reduction, <400 clinical academics) occurs 35 days after pandemic start for 11, 34, 62, 76 days respectively—with no clinical academics at all for 37 days in the “do-nothing” scenario. Restoration of normal academic workforce (80% of normal capacity) takes 11, 12, 30 and 26 weeks respectively. Conclusions Pandemic COVID-19 crushes the science needed at system level. National policies mitigate, but the academic community needs to adapt. We highlight six key strategies: radical prioritisation (eg 3–4 research ideas per institution), deep resourcing, non-standard leadership (repurposing of key non-frontline teams), rationalisation (profoundly simple approaches), careful site selection (eg protected sites with large academic backup) and complete suspension of academic competition with collaborative approaches.